Document is current
Any future updates will be listed below
-
Authors
Martikainen, Miika https://orcid.org/0000-0001-8202-701X
Lugano, Roberta
Pietilä, Ilkka
Brosch, Sofie
Cabrolier, Camille
Sivaramakrishnan, Aishwarya
Ramachandran, Mohanraj https://orcid.org/0000-0003-2685-0575
Yu, Di https://orcid.org/0000-0002-8636-0351
Dimberg, Anna https://orcid.org/0000-0003-4422-9125
Essand, Magnus https://orcid.org/0000-0002-9725-0422
-
Funding
Funding for this research was provided by:
Knut och Alice Wallenbergs Stiftelse (KAW 2019.0088)
Cancerfonden (190184Pj, 222241Pj)
Vetenskapsrådet (2019-01326, 2023-02232)
Barncancerfonden (PR2020-0167, PR2023-0103)
Hjärnfonden (FO2024-0302)
- License Information
-
More Information
Article History
Received: 24 October 2023
Accepted: 13 December 2024
First Online: 23 December 2024
Competing interests
: The authors declare no competing interests.
: The Swedish Work Environment Authority has approved the work with genetic modification of SFV (ID no. 202100-2932 v66a14 [laboratory] and v67a10 [mice]). All experiments regarding modified SFV were conducted under biosafety level 2. The local Animal Ethics Committee in Stockholm (13414/2020 and 04399/2023) approved the animal studies.
